A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer Meeting Abstract

  

Authors:	McArthur, H. L.; Comen, E. A.; Bryce, Y.; Solomon, S. B.; Leal, J. H. S.; Abaya, C. D.; Martinez, C.; Basho, R. K.; Park, D. J.; McAndrew, P.; Larkin, B.; Mills, W.; Page, D. B.; Mellinger, S. L.; Fredrich, N.; Moxon, N.; Reddy, S. M.; Carter, M.; Patil, S.; Norton, L.
Abstract Title:	A single-arm, phase 2 study of perioperative ipilimumab, nivolumab, and cryoablation in women with hormone receptor-negative, HER2-negative, early-stage/resectable breast cancer
Meeting Title:	2022 ASCO Annual Meeting
Journal Title:	Journal of Clinical Oncology
Volume:	40
Issue:	16 Suppl.
Meeting Dates:	2022 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2022-06-01
Language:	English
ACCESSION:	WOS:000863680305049
PROVIDER:	wos
DOI:	10.1200/JCO.2022.40.16_suppl.TPS617
Notes:	Meeting Abstract: TPS617 -- Meeting also held virtually -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/201479